Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 5 |
| List of Tables | 4 | 2 |
| List of Figures | 6 | 1 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 6 | 2 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 8 | 1 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 9 | 1 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 10 | 2 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Medical Devices Deals, 2010 to YTD 2016 | 12 | 1 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 13 | 4 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals &Healthcare, Deal Details | 17 | 52 |
| Venture Financing | 17 | 1 |
| Ambrx Raises USD45 Million in Venture Financing | 17 | 2 |
| Saladax Biomedical Raises US$23 Million In Series D Venture Financing | 19 | 2 |
| Partnerships | 21 | 1 |
| Nature's Sunshine Products Forms Joint Venture with Fosun Pharma | 21 | 2 |
| Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics | 23 | 1 |
| Maxigen Biotech Enters into Agreement with Shanghai Fosun Pharma | 24 | 1 |
| Biotest Enters Into Distribution Agreement With Wanbang Biopharma For Human Serum Albumin | 25 | 1 |
| Shanghai Fosun Enters Into Joint Venture With Dalian Wanchun To Develop Oncology Treatments | 26 | 1 |
| Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug | 27 | 1 |
| Shanghai Fosun Enters Into Joint Venture Agreement With Lonza Group | 28 | 1 |
| Licensing Agreements | 29 | 1 |
| Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences | 29 | 1 |
| TB Alliance Enters Into Licensing Agreement With Fosun Pharma | 30 | 2 |
| Shenzhen Salubris Pharma Enters Into Licensing Agreement With Shanghai Fosun Pharma For Diabetes Drug | 32 | 1 |
| Equity Offering | 33 | 1 |
| Shanghai Fosun Pharma Raises USD940 Million in Private Placement of Shares | 33 | 1 |
| Shanghai Fosun Pharma Decreases Size of Private Placement of Shares for USD376 Million | 34 | 2 |
| Shanghai Fosun Pharma to Raise Funds through Private Placement of Shares | 36 | 1 |
| Amerigen Pharma to Raise USD35 Million in Private Placement of Shares | 37 | 1 |
| Nature's Sunshine Raises USD46 Million in Private Placement of Shares | 38 | 2 |
| Shanghai Fosun Pharma Prices Private Placement Of Shares For US$229.6 Million | 40 | 1 |
| Chindex International Completes First Closing Of Private Placement Of Common Stock For US$14 Million | 41 | 2 |
| Debt Offering | 43 | 1 |
| Shanghai Fosun Pharma Plans to Raise USD928 Million in Private Placement of Bonds | 43 | 1 |
| Shanghai Fosun Pharma to Raise USD459 Million in First Tranche Public Offering of Bonds Due 2021 | 44 | 1 |
| Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 | 45 | 1 |
| Shanghai Fosun Pharma Announces Public Offering Of Corporate Bonds To Raise Up To US$469.8 Million | 46 | 1 |
| Shanghai Fosun Pharma Completes Offering Of Notes Due 2015 For US$149 Million | 47 | 1 |
| Asset Transactions | 48 | 1 |
| Sinopharm Plans to Acquire Pharmacy Business from Shanghai Fosun Pharma | 48 | 1 |
| Acquisition | 49 | 1 |
| Shanghai Fosun Pharma to Acquire 86% Stake in Gland Pharma for USD1.3 Billion | 49 | 2 |
| Shanghai Fosun Pharma to Acquire 2.6% Stake in Jinzhou Austrian Hong Pharma for USD26 Million | 51 | 1 |
| Shanghai Fosun Pharma, HOPU Investments, CEL Healthcare Fund and WuXi PharmaTech to Acquire Ambrx | 52 | 2 |
| Shanghai Fosun Pharma Plans to Acquire 65% Stake in Suzhou Erye for USD137 Million | 54 | 1 |
| Sinopharm Plans to Acquire Three Pharmacies from Shanghai Fosun Pharma for USD67 Million | 55 | 1 |
| Shanghai Fosun Pharma To Acquire Additional 28% Stake In Jinzhou Aohong Pharma For Up To US$304 Million | 56 | 1 |
| Fosun Pharma Acquires 50% Stake In Guangzhou Nanyang Tumour Hospital | 57 | 1 |
| Wanbang Biopharma Acquires 51% Stake In Zaozhuang Sainuokang | 58 | 1 |
| Shanghai No. 1 Pharmacy Plans To Acquire 50% Stake In Shanghai-Based Chain Pharmacy Company | 59 | 1 |
| Shanghai Fosun Pharma Completes Acquisition Of 77.78% Stake In Hunan Dongting Pharma For US$93 Million | 60 | 1 |
| Shanghai Fosun Pharma Completes Acquisition Of 55% Stake In Zhongwu Hospital | 61 | 1 |
| Fosun Pharma Acquires 11% Stake In Shenzhen Belter For US$7 Million | 62 | 1 |
| Fosun Pharma Acquires Additional Stake In Beijing Golden Elephant Pharmacy | 63 | 1 |
| Shanghai Fosun To Sell 68.6% Stake In Zhejiang Fosun To Sinopharm Group | 64 | 1 |
| Shanghai Fosun Pharma Acquires 75% Stake In Dalian Aleph Bio-medical | 65 | 1 |
| Shanghai Fosun Acquires 70% Stake In Shenyang Hongqi | 66 | 1 |
| Shanghai Fosun Pharma Acquires Minority Stake In Biosino Bio-Technology | 67 | 2 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Key Competitors | 69 | 1 |
| Key Employees | 70 | 2 |
| Locations And Subsidiaries | 72 | 1 |
| Head Office | 72 | 1 |
| Other Locations &Subsidiaries | 72 | 1 |
| Appendix | 73 | 1 |
| Methodology | 73 | 1 |
| About GlobalData | 73 | 1 |
| Contact Us | 73 | 1 |
| Disclaimer | 73 | 1 |